A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Summary

The purpose of this study is to understand safety and tolerability of the drug GSK1018921 after 14 days of dosing in healthy volunteers and then in patient volunteers.

Timeline

Start

2008-07

Primary completion

2008-10

Completion

2009-03

Outcome

Outcome not reported

Stopped (Business): “Study has now been terminated due to changes in project strategy. Current available data will be analysed and reported in a synoptic study report.”

Drugs

Indications